Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
Administration, Oral
Aged
Anticoagulants
/ administration & dosage
Atrial Fibrillation
/ complications
Catheter Ablation
/ adverse effects
Female
Humans
Intracranial Hemorrhages
/ chemically induced
Male
Middle Aged
Risk Assessment
Risk Factors
Thromboembolism
/ diagnostic imaging
Time Factors
Treatment Outcome
atrial fibrillation
catheter ablation
intracranial hemorrhage
oral anticoagulation
thromboembolic events
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
22
04
2019
accepted:
27
05
2019
pubmed:
2
7
2019
medline:
29
9
2020
entrez:
2
7
2019
Statut:
ppublish
Résumé
We sought to examine whether continuing oral anticoagulation (OAC) after catheter ablation (CA) for atrial fibrillation (AF) is associated with improved outcomes. OAC reduces morbidity and mortality in patients with AF. However, the continuation of OAC following the blanking period of CA is controversial due to conflicting published data. A systematic review of Medline, Cochrane, and Embase was performed for studies comparing patients who were continued on OAC (ON-OAC) vs those in which OAC was discontinued (OFF-OAC). CHA Five studies comprising 3956 patients were included (mean age, 61.1 ± 2.9 years; 72.4% male, CHA Continuation of OAC after CA of AF with CHA
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1250-1257Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 Wiley Periodicals Inc.